최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품영양과학회지 = Journal of the Korean Society of Food Science and Nutrition, v.35 no.5, 2006년, pp.549 - 556
양정화 (부산대학교 식품영양학과) , 한지숙 (부산대학교 식품영양학과)
The purpose of this study was to assess the effects of mulberry leaf extract supplement on blood glucose, glycated hemoglobin (
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Yoshikumi Y. 1996. Inhibition of intestinal $\alpha$ -glycosidase activity and postpranidal hyperglycemia by moranoline and its N-alkyl derivaties. Agric Biol Chem 52: 121-126
Asano N, Oseki K, Kizu H, Matsui K. 1994. Sugars with nitrogen in the ring isolated from the leaves of morus bombycis. Carbohydr Res 253: 235-245
Asano N, Oseki K, Tomioka E, Kizu H, Matsui K. 1994. N-containing sugars from morus alba and their glycosidase inhibitory activities. Carbohydr Res 259: 243-255
Enkhmoa B, Shiwaku K, Katsube T, Kitajima K, Anuurad E, Yamasaki M, Yamane Y. 2005. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonyl glucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J Nutr 135: 729-734
Onogi A, Osawa K, Yasuda H, Sakai A, Morita H, Tokawa H. 1993. Flavonol glycosides from the leaves of Morus alba. Shoyakugaku Zasshi 47: 423-425
Kim SY, Lee WC, Kim HB, Kim SK. 1998. Antihyper-lipidemic effects of methanol extracts from mulberry leaves in cholesterol induced hyperlipidemia in rats. J Korean Soc Food Sci Nutr 27: 1217-1222
Andallu B, Varadacharyulu NCH. 2003. Antioxidant role of mulberry leaves in streptozotocin-diabetic rats. Clin Chim Acta 338: 3-10
Sung YA. 2000. The prevention of type II diabetes. J Kor Med Assoc 43: 1103-1109
Lee KW, Shon BH, Kang SK, Park BK, Park DH, Min BS, Song HY. 1984. Epidemiologic study for diabetes in 1821 Koreans. Diabetes 8: 5-14
Lubbos H, Miller JL, Rose LI. 1995. Oral hypoglycemic agents in type II diabetes mellitus. Am Fam Physician 52: 2075-2078
Tattersall R. 1993. $\alpha$ -Glucosidase inhibition as an adjunct to the treatment of type 1 diabetes. Diabet Med 10: 688- 693
Campbell LK, White JR, Campbell RK. 1996. Acarbose: its role in the treatment of diabetes mellitus. Ann Pharmacother 30: 1255-1262
Nelson RW, Robertson J, Feldman EC, Briggs C. 2000. Effect of the alpha-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus. J Am Vet Med Assoc 216: 1265-1269
Hanefeld M. 1998. The role of acarbose in the treatment of non-insulin dependent diabetes mellitus. J Diabetes Com--plications 12: 228-237
Kimura M, Chen FJ, Nakashima N, Kimura I, Asano N, Koya S. 1995. Antihyperglycemic effects of N-containing sugars derived from mulberry leaves in streptozotocin- induced diabetic mice. J Traditional Med 12: 214-219
Chung SH, Kim MS, Choue RW. 1997. Effect of mori folium column fraction on intestinal $\alpha$ -glycosidase activity in mice administered with a high carbohydrate-containing diet. J Yakhak Hoeji 41: 485-487
Lee JS, Choi MH, Chung SH. 1995. Blood glucose-lowering effects of mori folium. J Yakhak Hoiji 39: 367-372
Mo SM, Lee YS, Goo JO, Son SM. Seo JS, Youn EY, Lee SK, Kim WK. 2002. Diet therapy. 2nd ed. Kyomunsa, Seoul. p 327
Korean Dietetic Association. 1999. Manual of medical nutrition therapy. 2nd ed. Korean Dietetic Association, Seoul. p 180
Lim SJ, Kim SY, Lee JW. 1994. The effect of Korean wild vegetables on blood glucose levels and liver muscle metabolism of streptozotocin-induced diabetic rats. Kor J Nutr 28: 819-827
Fuller JH, Stevens LK. 1991. Epidemiology of hypertension in diabetic patients and implications for treatment. Diabetes Care 14: 8-12
Kennedy DL, Piper JM, Baum C. 1988. Trends in use of oral hypoglycemic agent during 1964-1986. Diabetes Care 11: 558-562
Committee for establishment of hyperlipidemia therapy guide. 1996. Guideline for hyperlipidemia therapy. Seoul
Dunn FL. 1990. Hyperlipidemia in diabetes mellitus. Diabetes Metab Rev 6: 47-61
Kikuchi T, Onuma T, Schimura M, Tsutsui M, Boku A, Matsui J, Takebe K. 1994. Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM. Diabetes Care 17: 1059-1061
Kim YJ, Min HK, Choi YK, Lee TH, Hur GB, Shin SH. 1998. Diabetes. 2nd ed. Korea Medical Book Pub, Seoul. p 304-305
Song MK, Hong SG, Hwang SJ, Park OJ, Park MH. 2003. Improve effects of saengshik on patient with fatty liver and hyperlipidemia in murine. Kor J Nutr 36: 834-840
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.